PrimeLine IN5, Reducing Bovine Respiratory Disease Mortality (ft. Dr. Jeffery Hall)

What does it take for the USDA to allow a vaccine to carry a mortality reduction label claim? In this episode of Ahead of the Herd, Dr. Brian Dorcey is joined by Dr. Jeffery Hall and Morry Long from Huvepharma to discuss the science behind PrimeLine® IN5, a new intranasal Bovine Respiratory Disease (BRD) vaccine offering broad spectrum defense against IBR, BRSV, PI3, Pasteurella multocida, and reduces mortality associated with Mannheimia haemolytica. PrimeLine IN5 is safe for calves as young as three days old. The discussion covers the rigorous studies used to evaluate the vaccine, the significance of its rare USDA mortality reduction label claim, and why updated field isolates may play an important role in today's BRD prevention strategies. You'll also hear how intranasal vaccines stimulate both mucosal and systemic immunity, where PrimeLine IN5 fits into cow-calf, calf ranch, dairy, and stocker vaccination programs, and what Profectus veterinarians have observed through early field use. Whether you're evaluating your current vaccination program or looking for practical ways to reduce the impact of bovine respiratory disease, this episode offers valuable insights backed by science and real-world experience. Thank you for listening! If you enjoyed today's content, check us out on Facebook & YouTube for more! https://www.facebook.com/profile.php?id=61559700420623 Profectus Livestock Solutions - YouTube